About Onyx

Company: Alzheon

1 story

Latest stories

Page 1 of 1

Could a single pill crack the code of treating Alzheimer's disease?

By targeting toxic protein clumps in the brain, Dr. Martin Tolar, founder-CEO of Alzheon, aims to outsmart Alzheimer’s decades ahead of symptoms - and reshape global neurology.

Dr. Adil Ali 2 Jan 2025

Onyx reader offer

50%OFF

+ 25% off for a friend

15%OFF

your ticket

Ends in 5:00

Thank you for being an Onyx reader.

Meet more CEOs who share your interests at Cell & Gene Leaders Live. Sign up in the next five minutes to unlock your code.

Meet more CEOs who share your interests at Cell & Gene Leaders Live. Readers get 15% off tickets.

Sunday 15 November · The Shard, London

Your code, 15% off at checkout:

LLSW15

Book my ticket →

Enter the code on the payment page. Valid until 31 October.

Company: Alzheon

Latest stories

Could a single pill crack the code of treating Alzheimer's disease?

Biotech Events Guides & News

London Life Sciences Week Guide